Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 186

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1
Chunk 186
---
 hospital, healthcare facility
and physician practice group clients could suffer civil and criminal penalties, and be excluded from participating in Medicare, Medicaid
and other healthcare programs for failure to comply with applicable laws and regulations that may negatively affect our profitability.

A
portion of our hospital and healthcare facility clients are state and federal government agencies, where our ability to compete for new
contracts and orders, and the profitability of these contracts and orders, may be affected by government legislation, regulation or policy.
Additionally, in providing services to state and federal government clients and to clients who participate in state and federal programs,
we are also subject to specific laws and regulations, which government agencies have broad latitude to enforce. If we were to be excluded
from participation in these programs or should there be regulatory or policy changes or modification of application of existing regulations
adverse to us, it would likely materially adversely affect our brand, business, results of operations and cash flows.

-19-

Risks
Related to Our Class A Common Stock

Nasdaq
may delist our Class A common stock from trading on its exchange, which could limit investors’ ability to make transactions in
our Class A common stock and subject us to additional trading restrictions.

Our
Class A common stock is listed on the Nasdaq Capital Market and we expect to meet the minimum initial listing standards set forth in
the Nasdaq listing standards, we cannot assure you that our Class A common stock will be, or will continue to be, listed on Nasdaq in
the future. In order to continue listing our Class A common stock on Nasdaq, we must maintain certain financial, distribution and stock
price levels and must maintain a minimum number of holders of our Class A common stock.

If
Nasdaq delists our Class A common stock and we are not able to list our Class A common stock on another national securities exchange,
a reduction in some or all of the following may occur, each of which could have a material adverse effect on our stockholders:

    ●
    the
    liquidity of our Class A common stock;

    ●
    the
    market price of our Class A common stock;

    ●
    our
    ability to obtain financing for the continuation of our operations;

    ●
    the
    number of investors that will consider investing in our Class A common stock;

    ●
    the
    number of market makers in our Class A common stock;

    ●
    the
    availability of information concerning the trading prices and volume of our Class A common